How important are Key Opinion Leader discussions at ASCO24 on social media?What's more important, nu...
KOL Pulse Oncology Trends
Evaluation of HARMONi-2 Trial Discussions and Hype Analysis: Ivonescimab (Summit/Akeso) vs. Pembroli...
This Sunday, September 8, the HARMONI-2 Trial data will be presented at World Lung by Akeso, a China...